IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) announced today FDA clearance of MightySat ® Medical, making it the first and only FDA-cleared medical fingertip pulse oximeter available ...
Masimo Corporation MASI recently announced the FDA clearance of its Masimo SET-powered MightySat Medical Pulse Oximeter, available Over-The-Counter (OTC) to consumers without a prescription. This ...
Eliminating racial bias in pulse oximetry has been top of mind lately for many devicemakers and healthcare providers, as well as the FDA, which convened an advisory committee meeting earlier this ...
IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today announced that it has entered into a partnership with the National Basketball Association (NBA) to be its official supplier of pulse ...
MedPage Today on MSN
Pulse Oximeter Failings for Darker-Skinned People Might Not Have a Simple Solution
"Although absolute differences in readings were small, they can result in substantially higher rates of false negatives and ...
Masimo Corp.’s pulse oximetry technology avoids the dangerous under-recognition of low oxygen levels in people of color that plagues many pulse oximeters on the market, a peer-reviewed study in the ...
The launch of fingertip pulse oximeter Rainbow has proved disappointing thus far for Masimo ($MASI). But it's hoping that a new device, MightySat Rx Pulse Oximeter ...
Medical device creator Masimo announced today its latest 510(k) clearance from the U.S. Food and Drug Administration for the Rad-G pulse oximeter. The Rad-G is a handheld device that combines Masimo’s ...
Joe Kiani, Founder and CEO of Masimo, said, “Until now, consumers and even healthcare providers had no way of knowing what pulse oximeter they could trust to use at home. On the internet and even in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback